Ciprofibrate diminishes non-hdlc and improves hdlc in patients with frederickson type iv dyslipidemia phenotype

Objective: Hypertriacylglyceridemia and low HDLc combination is one of the most common lipidic abnormalities. Thus, the aim of thisstudy was to determine the effects of Ciprofibrate on patients with Frederickson’s Type IV dyslipidemia phenotype. Research designand methods: 75 patients with type IV d...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Archivos Venezolanos de Farmacología y Terapéutica
Autori principali:	M. Cabrera de B, A. Amell de D, N. Leal de P, R. Cano-Peñaloza, G. Puche-Medina, V. Bermúdez-Pirela, A. Souki, C. Cano-Ponce, F. Bermúdez-Arias, E. Mengual-Moreno, E. Leal-Gonzalez, M. Lemus-Antepaz, I. Ramirez, F. Contreras, M. Velasco
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Sociedad Venezolana de Farmacología Clínica y Terapéutica 2005
Soggetti:	Medicina
Accesso online:	https://www.redalyc.org/articulo.oa?id=55924203
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!